Anne E. Cooper
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 6
- Chemokine receptors and signaling 4
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Ken Grime (3 shared papers)Rolland E. Dickson (2 shared papers)Douglas D. Ferguson (1 shared paper)Charles D. Surh (2 shared papers)Ross L. Coppel (2 shared papers)Barry Hugo Hirst (2 shared papers)Vanessa Ann Moore (1 shared paper)Judy Van de Water (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Drug Metabolism and Disposition (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Current Drug Metabolism (2 papers)British Journal of Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Anne E. Cooper
21 papers receiving 799 citations
Peers
Comparison fields: 5 of 86
- Hepatology 188
- Pharmacology 77
- Oncology 223
- Epidemiology 164
- Pharmaceutical Science 29
Countries citing papers authored by Anne E. Cooper
This map shows the geographic impact of Anne E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Cooper more than expected).
Fields of papers citing papers by Anne E. Cooper
This network shows the impact of papers produced by Anne E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Cooper. The network helps show where Anne E. Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne E. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 181 | |
| 2 | 2004 | 121 | |
| 3 | 2012 | 93 | |
| 4 | 2004 | 78 | |
| 5 | 1988 | 61 | |
| 6 | 2005 | 47 | |
| 7 | 2012 | 42 | |
| 8 | 2003 | 38 | |
| 9 | 2002 | 31 | |
| 10 | 2005 | 25 | |
| 11 | 2010 | 23 | |
| 12 | 2010 | 22 | |
| 13 | 2004 | 21 | |
| 14 | 2006 | 17 | |
| 15 | 2013 | 10 | |
| 16 | 1990 | 8 | |
| 17 | 2012 | 6 | |
| 18 | 1996 | 5 | |
| 19 | 1995 | 5 | |
| 20 | 2021 | 5 |
About Anne E. Cooper
Anne E. Cooper is a scholar working on Oncology, Pharmacology, Immunology, Pulmonary and Respiratory Medicine and Physiology, having authored 22 papers that have together received 842 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Chemokine receptors and signaling (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Immunotherapy and Immune Responses (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Diabetes and associated disorders (2 papers), Asthma and respiratory diseases (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Hepatology (188 citations), Pharmacology (77 citations), Oncology (223 citations), Epidemiology (164 citations) and Pharmaceutical Science (29 citations). Anne E. Cooper has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Ken Grime, Rolland E. Dickson, Douglas D. Ferguson, Charles D. Surh, Ross L. Coppel, Barry Hugo Hirst, Vanessa Ann Moore, Judy Van de Water, Merrill Eric Gershwin and Aftab Ahmed Ansari. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Current Drug Metabolism and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.